CIK 0001357874
- Non-accelerated filer
- Smaller reporting company
PRECISION BIOSCIENCES INC
Sign in to watch- Ticker
- DTIL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- May 21
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 919-314-5512
- Business address
- 302 EAST PETTIGREW STREET, SUITE A-100, DURHAM, NC, 27701
- 4 Exercise or conversion Director acquired 9,826 shares (option exercise)
- 4 Exercise or conversion Director acquired 9,826 shares (option exercise)
- 4 Exercise or conversion Director acquired 9,826 shares (option exercise)
- 4 Exercise or conversion Director acquired 9,826 shares (option exercise)
- 4 Exercise or conversion Director acquired 9,826 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 4,523 shares at $4.67 ($21,122)
- 4 Open-market buy Director bought 1,839 shares at $4.75 ($8,735)
- 4 Open-market buy Director bought 3,250 shares at $5.30 ($17,225)
- 4 Planned sale President and CEO sold 964 shares at $5.56 ($5,360)
- 4 Planned sale Chief Research Officer sold 154 shares at $4.91 ($756)
- 4 Exercise or conversion Chief Financial Officer acquired 1,702 shares (option exercise)
- 4 Planned sale General Counsel and Secretary sold 272 shares at $4.91 ($1,336)
- 4 Planned sale General Counsel and Secretary sold 8,928 shares at $4.79 ($42,765)
- 4 Exercise or conversion Chief Financial Officer acquired 44,368 shares (option exercise)
- 4 Planned sale President and CEO sold 36,838 shares at $4.67 ($172,033)
- 4 Planned sale Chief Research Officer sold 10,287 shares at $4.79 ($49,275)
Page 3 of 14 · 269 filings